elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Ipilimumab
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Ipilimumab
RIS
0.001
(Research Intensity Score)
Papers
147
Top papers
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
2022 · 503 citations
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
2019 · 3728 citations
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
2021 · 1211 citations
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
2018 · 4676 citations
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma
2025 · 64 citations
Newest papers
Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review
2026 · 1 citations
Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer
2026 · 1 citations
First-line systemic treatment for people with extensive-stage small cell lung cancer: a network meta-analysis
2026
Innovative immunotherapies for prostate cancer: understanding the synergies between checkpoint inhibition, CAR T-cell therapy, and next-generation therapeutic modalities
2026 · 1 citations
Deep Response as a Novel Efficacy Endpoint in Hepatocellular Carcinoma
2026
A sample from the 100 top papers behind Ipilimumab.
Create a free account to browse them all →
Ipilimumab's history
Research intensity over time
Explore Ipilimumab's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Ipilimumab's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link